Source: Annual Congress 2006 - Mechanisms of acute lung injury and of fibrosis



Rating:

Share or cite this content

Citations should be made in the following way:
C. Glynos, A. Kotanidou, Z. Zhou, D. C. M. Simoes, C. Magkou, S. E. Orfanos, C. Roussos, A. Papapetropoulos (Athens, Patras, Greece). Soluble guanylyl cyclase expression is reduced in acute lung injury. Eur Respir J 2006; 28: Suppl. 50, 2350

Member's Comments

No comment yet.

Related content which might interest you: Down-regulation of soluble guanylyl cyclase in asthma contributes to airway hyperreactivity Source: Eur Respir J 2005; 26: Suppl. 49, 581s Year: 2005 The stimulator of soluble guanylate cyclase riociguat protects against bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Resistive breathing reduces soluble guanylyl cyclase expression Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 sGC activator BAY 412272 attenuates ischemia/reperfusion injury of the lung Source: Eur Respir J 2006; 28: Suppl. 50, 822s Year: 2006 Soluble guanylate cyclase stimulator riociguat prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats Source: Annual Congress 2011 - Translational models of disease Year: 2011 Soluble guanylate cyclase stimulators revert in vitro cigarette smoke effects through JNK pathway normalization Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension Source: Eur Respir J 2009; 33: 785-792 Year: 2009 Effects of soluble guanylate cyclase (sGC) stimulation in guinea pigs chronically exposed to cigarette smoke Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Effects of a soluble guanylate cyclase stimulator, BAY 41-8543, upon right ventricular function in experimental pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 RAGE deficiency improves alveolar fluid clearance in LPS-induced acute lung injury by preventing downregulation of Na-K-ATPase and ENaC Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 The role of soluble guanylyl cyclase in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern Source: Eur Respir J 2009; 33: 717-721 Year: 2009 Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with renal impairment Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy Source: Eur Respir Rev 2009; 18: 35-41 Year: 2009 Molecular mechanisms involved in the therapeutic action of the stimulation of soluble guanylate cyclase (sGC) in an experimental model of guinea pig exposed to cigarette smoke Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Inhibition of neutrophil apoptosis by sphingosin-1-phopsphate through the activation of neutral sphingomyelinase in acute lung injury Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Hypoxia-mediated alterations in adenosine receptor expression in rat lung Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function Source: Eur Respir J 2011; 37: 349 Year: 2011 Effect of protein S on lipopolysaccharide-induced acute lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 398s Year: 2006 Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013